Professor Elio Riboli is Chair in Cancer Epidemiology and Prevention at Imperial College London, and sits as a delegate core member of the CPE Steering Group, leading on Project 6, CPE Roadmap, with a position paper under development. Professor Riboli has led innovative research on the role of diet, nutrition and metabolic factors in cancer causation and initiated the European Prospective Investigation into Cancer and Nutrition (EPIC) that recruited over half a million participants in 10 European Countries and established the first dedicated large-scale population biobank. Over the past three decades, Professor Riboli has been leading research based on EPIC and other prospective cohort studies focused on the investigation of the nutritional, metabolic and genetic factors in the causation and prevention of cancer and other NCDs. He was the founding director of the School of Public Health at Imperial College (2011-2018). Since 2024 he is Medical and Scientific Adviser at World Cancer Research Fund International.
I have had the pleasure of being part of CPE since its establishment and to have enjoyed the very constructive interactions with many colleagues representing outstanding European cancer and public health research institutions. The CPE focus on public health translation of cancer epidemiology results is particularly important and at the same time very challenging. It has been very stimulating to work together to review cancer prevention achievements and at the same time to identify some past shortcomings and future challenges. The creation and growth of CPE created a unique interactive space in the area of cancer prevention.
